| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/20/2006 | US7063834 Cosmetic compositions based on multiblock ionizable polycondensates, and uses thereof |
| 06/20/2006 | US7063832 Treating musculoskeletal pain or restless leg syndrome by breathing a muscle relaxant condensation aerosol having a mass median aerodynamic diameter (MMAD) of <3 mu m and <5% relaxant degradation products; kits; heating a coating of drug on a support to vaporize and passing air through the heated vapors |
| 06/20/2006 | US7063831 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | CA2350943C Process for the manufacture of liquid filled capsules |
| 06/20/2006 | CA2301018C Hyaluronic acid gel, method of its production and medical material containing it |
| 06/20/2006 | CA2260423C Pharmaceutical composition of hedgehog proteins and use thereof |
| 06/20/2006 | CA2237192C Photocured crosslinked-hyaluronic acid gel and method of preparation thereof |
| 06/20/2006 | CA2220103C Composition comprising amoxycillin and clavulanic acid |
| 06/20/2006 | CA2173553C Dextrin ester of fatty acids and use thereof |
| 06/15/2006 | WO2006062807A2 Compositions with enhanced immunogenicity |
| 06/15/2006 | WO2006062581A2 Delivery of therapeutic rnai agents for treating restenosis |
| 06/15/2006 | WO2006062089A1 Composition composed of highly dispersible cellulose complex and polysaccharide |
| 06/15/2006 | WO2006062077A1 Film coating composition, coating film thereof, and tablet |
| 06/15/2006 | WO2006061990A1 Liquid agent composition for contact lens |
| 06/15/2006 | WO2006061697A1 Sulfonylurea compositions and a process for its preparation |
| 06/15/2006 | WO2006061689A1 Topical drug delivery system |
| 06/15/2006 | WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature |
| 06/15/2006 | WO2006061214A1 Anthelmintic composition |
| 06/15/2006 | WO2006061156A2 Medicament for hygienic application inside the ear |
| 06/15/2006 | WO2006061155A2 Stabilisation of glucocorticoid esters with acids |
| 06/15/2006 | WO2006042324A3 Antifungal composition applicable to body tissue, preferably nails |
| 06/15/2006 | WO2006023377A3 Biomimetic of evodia rutaecarpa fruit extract for amelioration of inflammation |
| 06/15/2006 | WO2006007662A8 Methods for increasing foam stability |
| 06/15/2006 | WO2005117986A3 Antibody drug conjugates and methods |
| 06/15/2006 | WO2005110436A3 Macromolecule-containing sustained release intraocular implants and related methods |
| 06/15/2006 | WO2005102269A3 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production |
| 06/15/2006 | WO2005092380A3 Uses of anti-ctla-4 antibodies |
| 06/15/2006 | WO2005084715A3 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
| 06/15/2006 | WO2005084638A3 Formulations decreasing infectivity of pulmonary diseases |
| 06/15/2006 | WO2005072777A3 Conjugates of amyloid proteins as vaccines for amyloid-related diseases |
| 06/15/2006 | WO2005065718A3 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine |
| 06/15/2006 | WO2005023176A3 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/15/2006 | WO2005021043A3 High-molecular-mass prodrugs |
| 06/15/2006 | WO2004060299A3 Polymer conjugates of interferon-beta with enhanced biological potency |
| 06/15/2006 | WO2004052336A3 High viscosity liquid controlled delivery system and medical or surgical device |
| 06/15/2006 | US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/15/2006 | US20060128947 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 06/15/2006 | US20060128938 Lactic acid polymer and process for producing the same |
| 06/15/2006 | US20060128736 Camptothecin-carboxylate formulations |
| 06/15/2006 | US20060128666 Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128641 Levamisole, avermectins or similar in pyrrolidone solvent |
| 06/15/2006 | US20060128625 A growth factor formulation comprising: a polypeptide of the TGF- beta (tranformation growth factor) superfamily, N-vinyl-2-pyrrolidone polymer carrier and a solvent selected from water and aqueous buffer solutions |
| 06/15/2006 | US20060128621 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 06/15/2006 | US20060128017 Process for the production of an active molecule vector used to diffuse active substances and vector thus obtained |
| 06/15/2006 | US20060127899 Active carbohydrate containing protecting reagents for chemical modifications, their production and use |
| 06/15/2006 | US20060127891 RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA) |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/15/2006 | US20060127508 Preparation for the relief of disease |
| 06/15/2006 | US20060127499 Vitamin-mineral compositions |
| 06/15/2006 | US20060127487 Antiviral compositions |
| 06/15/2006 | US20060127485 Bio-degradable colloid particles, in particular for pulmonary applications |
| 06/15/2006 | US20060127484 Controlled release composition |
| 06/15/2006 | US20060127481 Ophthalmic drug delivery system using polymer micell |
| 06/15/2006 | US20060127477 Novel preparation and administration form comprising an acid-labile active compound |
| 06/15/2006 | US20060127475 tablet comprising disintegrant such as carmellose, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose |
| 06/15/2006 | US20060127470 Use of buckysome or carbon nanotube for drug delivery |
| 06/15/2006 | US20060127469 Entrapping in phosphatidylcholine component; room temperature transdermal delivery system; long shelf life |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127460 Trombin-carrying bioabsorbable synthetic nonwoven fabric |
| 06/15/2006 | US20060127450 Composition containing higher fatty acid derivative and foods and drinks |
| 06/15/2006 | US20060127449 Method and composition for lowering cholesterol |
| 06/15/2006 | US20060127448 Use of low-glycemic sweeteners in food and beverage compositions |
| 06/15/2006 | US20060127447 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127423 Organic compounds |
| 06/15/2006 | US20060127420 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127352 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 06/15/2006 | US20060127350 Dendrimer conjugates for selective of protein aggregates |
| 06/15/2006 | US20060127349 Administering water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/15/2006 | US20060127348 Chemically and/or biologically reactive compounds |
| 06/15/2006 | US20060127330 Composition for treating and/or preventing periodontal disease |
| 06/15/2006 | US20060127322 Stable pharmaceutical Budesonide preparation for producing propellant-free aerosols |
| 06/15/2006 | US20060127310 Amplification of biotin-mediated targeting |
| 06/15/2006 | US20060127307 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 06/15/2006 | CA2594103A1 Medicament for hygienic application inside the ear |
| 06/15/2006 | CA2591296A1 Stabilisation of glucocorticoid esters with acids |
| 06/15/2006 | CA2591203A1 Topical drug delivery system |
| 06/14/2006 | EP1669379A1 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents |
| 06/14/2006 | EP1669374A1 Method for forming aqueous secondary dispersions of water insoluble polymers |
| 06/14/2006 | EP1669093A1 Polyoxyalkylene copolymer blends as biomaterial for drug delivery and surface modification |
| 06/14/2006 | EP1669091A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/14/2006 | EP1669090A1 Bitterness-masking particulate jelly beverage |
| 06/14/2006 | EP1669087A1 Preparation containing basic drug |
| 06/14/2006 | EP1669082A1 Dried extract from inflammatory rabbit skin inoculated with vaccinia virus and process for its manufacture |
| 06/14/2006 | EP1669073A2 Fulvestrant formulation |
| 06/14/2006 | EP1669066A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 06/14/2006 | EP1669065A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 06/14/2006 | EP1668424A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 06/14/2006 | EP1668358A1 Reconstitution medium for protein and peptide formulations |
| 06/14/2006 | EP1668062A2 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 06/14/2006 | EP1667735A2 Inhibition of inward sodium currents in cancer |
| 06/14/2006 | EP1667734A2 Optical imaging of colorectal cancer |
| 06/14/2006 | EP1667732A1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 06/14/2006 | EP1667728A1 Intravascular delivery of non-viral nucleic acid |
| 06/14/2006 | EP1667727A2 Polyamine-metal chelator conjugates |
| 06/14/2006 | EP1667726A2 Polyacetal drug conjugates as release system |